Company / Gross Profit per Share
Processa Pharmaceuticals, Inc. Gross Profit per Share History
FY2013-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
-$0.00
FY2016
5-year range
-$0.00 / $0.02
FY2013-FY2016
Trend
-130.6%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has declined for 3 consecutive years, from $0.03 in FY2013 to $-0.00 in FY2016.
Based on SEC 10-K filings.
-0.00 in FY2016.
Declined from $0.02 to $-0.00 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Processa Pharmaceuticals, Inc.'s gross profit per share has declined for 3 consecutive years.
- In FY2016, gross profit per share decreased 130.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | - | - |
| FY2016 | -$0.00 | -130.6% |
| FY2015 | $0.00 | -76.0% |
| FY2014 | $0.02 | -51.8% |
| FY2013 | $0.03 | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026